Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Dynamic Pharmaceuticals Invesco ETF (PJP)

Dynamic Pharmaceuticals Invesco ETF (PJP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Invesco
  • Assets Under Management 371,241,000
  • Market Capitalization, $K 371,241
  • Shares Outstanding, K 5,700
  • 60-Month Beta 1.07
  • Price/Earnings ttm 12.39
  • Annual Dividend & Yield 0.50 (0.77%)
  • Most Recent Dividend 0.162 on 12/23/19
  • Management Fee 0.56%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
62.40 +4.72%
on 01/31/20
66.75 -2.11%
on 02/11/20
-0.87 (-1.31%)
since 01/17/20
3-Month
60.90 +7.29%
on 11/21/19
66.75 -2.11%
on 02/11/20
+3.62 (+5.87%)
since 11/19/19
52-Week
54.86 +19.10%
on 10/03/19
69.38 -5.82%
on 03/04/19
-1.55 (-2.32%)
since 02/19/19

Most Recent Stories

More News
Pharma ETFs Gain on Healthy Q4 Earnings

Strong results led to solid trading in pharma ETFs over the past week.

PPH : 66.52 (+0.29%)
PJP : 65.34 (+0.33%)
XPH : 46.48 (+0.37%)
IHE : 159.94 (-0.21%)
FTXH : 23.63 (-0.08%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 66.52 (+0.29%)
NVO : 64.14 (+0.08%)
ABBV : 94.14 (+0.57%)
BMY : 65.71 (-0.54%)
PJP : 65.34 (+0.33%)
IHE : 159.94 (-0.21%)
Pharma Sector Tops in October: Best ETFs & Stocks

Pharma sector wins in October, making these ETFs and stocks winners.

PPH : 66.52 (+0.29%)
XPH : 46.48 (+0.37%)
PJP : 65.34 (+0.33%)
ALXN : 103.21 (+1.03%)
BIIB : 341.04 (+1.17%)
ACHN : 6.76 (+10.28%)
DERM : 18.75 (+0.05%)
GLYC : 4.23 (-2.08%)
RIGL : 2.31 (+2.67%)
IRWD : 11.93 (-1.45%)
Pharma ETFs Set to Benefit Post Strong Q3 Earnings

Robust results led to solid trading in pharma ETFs in a month.

XPH : 46.48 (+0.37%)
PJP : 65.34 (+0.33%)
PPH : 66.52 (+0.29%)
IHE : 159.94 (-0.21%)
FTXH : 23.63 (-0.08%)
Amgen to Buy Celgene's Otezla: 5 ETF Drugs

Amgen agreed to buy psoriasis and psoriatic arthritis drug Otezla from Celgene for $13.4 billion in cash.

NVS : 97.22 (+0.02%)
BMY : 65.71 (-0.54%)
BBH : 144.73 (+0.91%)
PJP : 65.34 (+0.33%)
IBB : 123.48 (+0.78%)
PBE : 56.37 (+0.36%)
CELG : 108.24 (+0.10%)
AMGN : 222.96 (+0.57%)
IEIH : 28.69 (+0.32%)
Pharma Q2 Earnings Growth Highest: Time to Buy ETFs?

Despite robust results, pharma ETFs have been trending downward in a month.

PJP : 65.34 (+0.33%)
XPH : 46.48 (+0.37%)
PPH : 66.52 (+0.29%)
IHE : 159.94 (-0.21%)
FTXH : 23.63 (-0.08%)
AbbVie to Buy Allergan: Prescribed ETFs

AbbVie has agreed to buy Botox-maker Allergan for $63 billion in a cash-and-stock deal. The news has put the spotlight on a number of healthcare ETFs.

BMY : 65.71 (-0.54%)
AGN : 198.81 (+0.41%)
ABBV : 94.14 (+0.57%)
BBH : 144.73 (+0.91%)
PPH : 66.52 (+0.29%)
XPH : 46.48 (+0.37%)
IHE : 159.94 (-0.21%)
PJP : 65.34 (+0.33%)
CELG : 108.24 (+0.10%)
Pharma ETFs Down Despite Solid Q1 Results

Despite such robust results, pharma ETFs have been trending downward in a month.

XPH : 46.48 (+0.37%)
PJP : 65.34 (+0.33%)
IHE : 159.94 (-0.21%)
PPH : 66.52 (+0.29%)
FTXH : 23.63 (-0.08%)
Pharma ETFs Down Despite Solid Q1 Results

Despite such robust results, pharma ETFs have been trending downward in a month.

XPH : 46.48 (+0.37%)
PJP : 65.34 (+0.33%)
IHE : 159.94 (-0.21%)
PPH : 66.52 (+0.29%)
FTXH : 23.63 (-0.08%)
4 Sector ETFs That Crushed S&P 500 in Decade-Old Bull Run

These sector ETFs emerged winners in the 10-year old bull market.

XLY : 132.27 (+0.45%)
FBT : 155.87 (+0.93%)
PJP : 65.34 (+0.33%)
FXH : 89.54 (+0.81%)
FDN : 154.39 (+0.15%)
VCR : 204.12 (+0.67%)
XBI : 98.35 (+0.76%)
QTEC : 109.31 (+1.54%)
SPY : 338.34 (+0.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade PJP with:

Fund Summary

The Invesco Dynamic Pharmaceuticals ETF is based on the Dynamic Pharmaceutical Intellidex Index. The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies...

See More

Top 10 Holdings

Key Turning Points

2nd Resistance Point 65.63
1st Resistance Point 65.49
Last Price 65.34
1st Support Level 65.07
2nd Support Level 64.79

See More

52-Week High 69.38
Last Price 65.34
Fibonacci 61.8% 63.83
Fibonacci 50% 62.12
Fibonacci 38.2% 60.41
52-Week Low 54.86

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar